Filters

Clear all

Expert Opinion

Plain Language Summary

Expert Review

Text Availability

Abstract

Full text

Free full text

Publication Types

Journal Article

Research Support, Non-U.S. Gov't

Review

Research Support, N.I.H., Extramural

Clinical Trial, Phase I

Multicenter Study

Clinical Trial, Phase II

Randomized Controlled Trial

Clinical Trial, Phase III

Comparative Study

Research Support, N.I.H., Intramural

Meta-Analysis

Case Reports

Clinical Trial

Publication Year

From

Quick links

Individual year

2026

2025

2024

2023

2021

2020

2019

2018

2017

2016

2015

2013

2012

2011

2010

2007

2003

Sort by:

selected

Print page

Email selected articles

Favourite selected articles

Create a NED Search Alert for this search

Save this search

Advanced Search

Run an advanced search

Results for
""Proto-Oncogene Proteins c-met""[mesh_terms]

46 Results

Searching titles within these results

Meta-analysis of functional expression and mutational analysis of c-Met in various cancers.

Murugesan Sivakumar, Murugesan Jayakumar, Palaniappan Seedevi, Palaniappan Sivasankar, Muthu Ravikumar, Sundharaiyya Surendar, Tamilselvi Murugan, Shahid S Siddiqui, Sivakumar Loganathan

Current problems in cancer 2021;44(4):100515

Full Text

Abstract

HGF/c-Met Signalling in the Tumor Microenvironment.

Alberto Zambelli, Giuseppe Biamonti, Angela Amato

Advances in experimental medicine and biology 2021;1270():31-44

Full Text

Abstract

c-MET pathway in human malignancies and its targeting by natural compounds for cancer therapy.

Chakrabhavi Dhananjaya Mohan, Muthu K Shanmugam, Siddegowda Gopalapura Shivanne Gowda, Arunachalam Chinnathambi, Kanchugarakoppal S Rangappa, Gautam Sethi

Phytomedicine : international journal of phytotherapy and phytopharmacology 2024;128():155379

Full Text

Abstract

New chemical treatment options in second-line hepatocellular carcinoma: what to do when sorafenib fails?

Hyun Young Woo, So Young Yoo, Jeong Heo

Expert opinion on pharmacotherapy 2017;18(1):35-44

Full Text

Abstract

Phytochemicals Neogitogenin and Samogenin Hold Potentials for Hepatocyte Growth Factor Receptor-Targeted Cancer Treatment.

Taj Mohammad, Alaa Shafie, Md Imtaiyaz Hassan, Farah Anjum, Abdelbaset Mohamed Elasbali, Bodour Ali Al-Ghabban

Omics : a journal of integrative biology 2024;28(11):573-583

Full Text

Abstract

Biophysical and structural characterization of the impacts of MET phosphorylation on tepotinib binding.

Ulrich Grädler, Daniel Schwarz, Ansgar Wegener, Thomas Eichhorn, Tiago M Bandeiras, Micael C Freitas, Alfred Lammens, Oleg Ganichkin, Martin Augustin, Stefano Minguzzi, Frank Becker, Jörg Bomke

The Journal of biological chemistry 2023;299(11):105328

Free Full Text

Abstract

Tivantinib for the treatment of hepatocellular carcinoma.

Jan Best, Clemens Schotten, Gregor Lohmann, Guido Gerken, Alexander Dechêne

Expert opinion on pharmacotherapy 2017;18(7):727-733

Full Text

Abstract

Natural Monoterpene Stylosin Induced Anticancer Effects on Human Colon Carcinoma Cells.

Sara Seyedshazileh, Amirabbas Abdollahi, Mehrdad Iranshahi, Fatemeh B Rassouli

Pharmacology research & perspectives 2026;14(3):e70287

Free Full Text

Abstract

Prevalence and clinical impact of Met Y1253D-activating point mutation in radiotherapy-treated squamous cell cancer of the oropharynx.

Daniel M Aebersold, Olfert Landt, Sylvie Berthou, Günther Gruber, Karl T Beer, Richard H Greiner, Yitzhak Zimmer

Oncogene 2003;22(52):8519-23

Full Text

Abstract

Assessing potential peptide targeting ligands by quantification of cellular adhesion of model nanoparticles under flow conditions.

Ellen Broda, Frauke Martina Mickler, Ulrich Lächelt, Stephan Morys, Ernst Wagner, Christoph Bräuchle

Journal of controlled release : official journal of the Controlled Release Society 2016;213():79-85

Full Text

Abstract

Decorin is a devouring proteoglycan: Remodeling of intracellular catabolism via autophagy and mitophagy.

Simone Buraschi, Thomas Neill, Renato V Iozzo

Matrix biology : journal of the International Society for Matrix Biology 2019;75-76():260-270

Free Full Text

Abstract

Single-molecule imaging and molecular dynamics simulations reveal early activation of the MET receptor in cells.

Yunqing Li, Luisa Iamele, Hugo de Jonge, Davide M Ferraris, Hartmut H Niemann, Marina S Dietz, Mike Heilemann, Serena M Arghittu, Gabriel J Hella, Daniel Haße, Petra Freund, Hans-Dieter Barth, Roberto Covino

Nature communications 2024;15(1):9486

Free Full Text

Abstract

Solution structure of SHIP2 SH2 domain and its interaction with a phosphotyrosine peptide from c-MET.

Zi Wang, Yao Nie, Kunxiao Zhang, Henghao Xu, Theresa A Ramelot, Michael A Kennedy, Maili Liu, Jiang Zhu, Yunhuang Yang

Archives of biochemistry and biophysics 2019;656():31-37

Free Full Text

Abstract

Receptor tyrosine kinase MET as potential target of multi-kinase inhibitor and radiosensitizer sorafenib in HNSCC.

Kaweh Beizaei, Lisa Gleißner, Konstantin Hoffer, Lara Bußmann, Anh Thu Vu, Leonhard Steinmeister, Simon Laban, Nikolaus Möckelmann, Adrian Münscher, Cordula Petersen, Kai Rothkamm, Malte Kriegs

Head & neck 2020;41(1):208-215

Full Text

Abstract

Phase 1 study of safety, pharmacokinetics, and pharmacodynamics of tivantinib in combination with bevacizumab in adult patients with advanced solid tumors.

William F Maguire, John C Schmitz, Jonas Scemama, Ken Czambel, Yan Lin, Anthony G Green, Shaoyu Wu, Huang Lin, Shannon Puhalla, John Rhee, Ronald Stoller, Hussein Tawbi, James J Lee, John J Wright, Jan H Beumer, Edward Chu, Leonard J Appleman

Cancer chemotherapy and pharmacology 2021;88(4):643-654

Free Full Text

Abstract

Results: 1 – 15 / 46

Filters

Expert Opinion

Text Availability

Publication Types

Publication Year

Results for ""Proto-Oncogene Proteins c-met""[mesh_terms]

Meta-analysis of functional expression and mutational analysis of c-Met in various cancers.

HGF/c-Met Signalling in the Tumor Microenvironment.

c-MET pathway in human malignancies and its targeting by natural compounds for cancer therapy.

New chemical treatment options in second-line hepatocellular carcinoma: what to do when sorafenib fails?

Phytochemicals Neogitogenin and Samogenin Hold Potentials for Hepatocyte Growth Factor Receptor-Targeted Cancer Treatment.

Biophysical and structural characterization of the impacts of MET phosphorylation on tepotinib binding.

Tivantinib for the treatment of hepatocellular carcinoma.

Natural Monoterpene Stylosin Induced Anticancer Effects on Human Colon Carcinoma Cells.

Prevalence and clinical impact of Met Y1253D-activating point mutation in radiotherapy-treated squamous cell cancer of the oropharynx.

Assessing potential peptide targeting ligands by quantification of cellular adhesion of model nanoparticles under flow conditions.

Decorin is a devouring proteoglycan: Remodeling of intracellular catabolism via autophagy and mitophagy.

Single-molecule imaging and molecular dynamics simulations reveal early activation of the MET receptor in cells.

Solution structure of SHIP2 SH2 domain and its interaction with a phosphotyrosine peptide from c-MET.

Receptor tyrosine kinase MET as potential target of multi-kinase inhibitor and radiosensitizer sorafenib in HNSCC.

Phase 1 study of safety, pharmacokinetics, and pharmacodynamics of tivantinib in combination with bevacizumab in adult patients with advanced solid tumors.

Results for
""Proto-Oncogene Proteins c-met""[mesh_terms]